debrisoquin has been researched along with Neuroses in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertilsson, L | 1 |
| Dahl, ML | 1 |
| Sjöqvist, F | 1 |
| Aberg-Wistedt, A | 1 |
| Humble, M | 1 |
| Johansson, I | 1 |
| Lundqvist, E | 1 |
| Ingelman-Sundberg, M | 1 |
1 other study available for debrisoquin and Neuroses
| Article | Year |
|---|---|
Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine.
Topics: Debrisoquin; Female; Humans; Hydroxylation; Metabolic Diseases; Neurotic Disorders; Polymorphism, Re | 1993 |